Among numerous proteins identified by the proteomic comparison of drug-sensitive and resistant glioma cells, lipocalin 2 (LCN2) [38] and integrin β3 (ITGB3) [39] played a central role in regulating glioma chemosensitivity (Fig. 5). Here, LCN2 is linked to glioma.